Absorption kinetics of oxalate from oxalate-rich food in man von Prenen, J A, Boer, P, Dorhout Mees, E J

Volltext

Varicocele scintigraphy : A simplified screening method for the detection of spermatic vein reflux von PRENEN, J. A. C, VAN DIS, P, FEIJEN, H. L. M

Volltext

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis von Gharahkhani, Puya, Dr, Fitzgerald, Rebecca C, MD, Vaughan, Thomas L, MD, Palles, Claire, PhD, Gockel, Ines, Prof, Tomlinson, Ian, MD, Buas, Matthew F, PhD, May, Andrea, MD, Gerges, Christian, MD, Anders, Mario, Prof, Becker, Jessica, PhD, Kreuser, Nicole, BSc, Noder, Tania, BN, Venerito, Marino, MD, Veits, Lothar, MD, Schmidt, Thomas, MD, Manner, Hendrik, MD, Schmidt, Claudia, MD, Hess, Timo, MSc, Böhmer, Anne C, PhD, Izbicki, Jakob R, Prof, Hölscher, Arnulf H, Prof, Lang, Hauke, Prof, Lorenz, Dietmar, MD, Schumacher, Brigitte, MD, Hackelsberger, Andreas, MD, Mayershofer, Rupert, MD, Pech, Oliver, MD, Vashist, Yogesh, MD, Ott, Katja, MD, Vieth, Michael, MD, Weismüller, Josef, MD, Nöthen, Markus M, Prof, Attwood, Stephen, MD, Barr, Hugh, MD, Chegwidden, Laura, MSc, de Caestecker, John, MD, Harrison, Rebecca, MD, Love, Sharon B, MSc, MacDonald, David, DDS, Moayyedi, Paul, MD, Prenen, Hans, MD, Watson, R G Peter, MD, Iyer, Prasad G, MD, Anderson, Lesley A, PhD, Bernstein, Leslie, PhD, Chow, Wong-Ho, PhD, Hardie, Laura J, PhD, Lagergren, Jesper, Prof, Liu, Geoffrey, MD, Risch, Harvey A, MD, Wu, Anna H, PhD, Ye, Weimin, Prof, Bird, Nigel C, MD, Shaheen, Nicholas J, MD, Gammon, Marilie D, PhD, Corley, Douglas A, MD, Caldas, Carlos, PhD, Moebus, Susanne, Prof, Knapp, Michael, PhD, Peters, Wilbert H M, MD, Neuhaus, Horst, MD, Rösch, Thomas, Prof, Ell, Christian, MD, MacGregor, Stuart, PhD, Pharoah, Paul, PhD, Whiteman, David C, Prof, Jankowski, Janusz, Prof, Schumacher, Johannes, MD

Volltext

Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis von De Smedt, L, Lemahieu, J, Palmans, S, Govaere, O, Tousseyn, T, Van Cutsem, E, Prenen, H, Tejpar, S, Spaepen, M, Matthijs, G, Decaestecker, C, Moles Lopez, X, Demetter, P, Salmon, I, Sagaert, X

Volltext

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study von Van Cutsem, E., Boni, C., Tabernero, J., Massuti, B., Middleton, G., Dane, F., Reichardt, P., Pimentel, F.L., Cohn, A., Follana, P., Clemens, M., Zaniboni, A., Moiseyenko, V., Harrison, M., Richards, D.A., Prenen, H., Pernot, S., Ecstein-Fraisse, E., Hitier, S., Rougier, P.

Volltext

First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration von Rodon, J., Prenen, H., Sacher, A., Villalona-Calero, M., Penel, N., El Helali, A., Rottey, S., Yamamoto, N., Ghiringhelli, F., Goebeler, M.E., Doi, T., Postel-Vinay, S., Lin, C.-C., Liu, C., Chuang, C.-H., Keyvanjah, K., Eggert, T., O’Neil, B.H.

Volltext

Efficacy of the Kinase Inhibitor SU11248 against Gastrointestinal Stromal Tumor Mutants Refractory to Imatinib Mesylate von PRENEN, Hans, COOLS, Jan, MENTENS, Nicole, FOLENS, Cedric, SCIOT, Raf, SCHÖFFSKI, Patrick, VAN OOSTEROM, Allan, MARYNEN, Peter, DEBIEC-RYCHTER, Maria

Volltext

Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus von Palles, Claire, Chegwidden, Laura, Li, Xinzhong, Findlay, John M, Farnham, Garry, Castro Giner, Francesc, Peppelenbosch, Maikel P, Kovac, Michal, Adams, Claire L, Prenen, Hans, Briggs, Sarah, Harrison, Rebecca, Sanders, Scott, MacDonald, David, Haigh, Chris, Tucker, Art, Love, Sharon, Nanji, Manoj, deCaestecker, John, Ferry, David, Rathbone, Barrie, Hapeshi, Julie, Barr, Hugh, Moayyedi, Paul, Watson, Peter, Zietek, Barbara, Maroo, Neera, Gay, Laura, Underwood, Tim, Boulter, Lisa, McMurtry, Hugh, Monk, David, Patel, Praful, Ragunath, Krish, Al Dulaimi, David, Murray, Iain, Koss, Konrad, Veitch, Andrew, Trudgill, Nigel, Nwokolo, Chuka, Rembacken, Bjorn, Atherfold, Paul, Green, Elaine, Ang, Yeng, Kuipers, Ernst J, Chow, Wu, Paterson, Stuart, Kadri, Sudarshan, Beales, Ian, Grimley, Charles, Mullins, Paul, Beckett, Conrad, Farrant, Mark, Dixon, Andrew, Kelly, Sean, Johnson, Matthew, Wajed, Shahjehan, Dhar, Anjan, Sawyer, Elinor, Roylance, Rebecca, Onstad, Lynn, Gammon, Marilie D, Corley, Douglas A, Shaheen, Nicholas J, Bird, Nigel C, Hardie, Laura J, Reid, Brian J, Ye, Weimin, Liu, Geoffrey, Romero, Yvonne, Bernstein, Leslie, Wu, Anna H, Casson, Alan G, Fitzgerald, Rebecca, Whiteman, David C, Risch, Harvey A, Levine, David M, Vaughan, Tom L, Verhaar, Auke P, van den Brande, Jan, Toxopeus, Eelke L, Spaander, Manon C, Wijnhoven, Bas P.L, van der Laan, Luc J.W, Krishnadath, Kausilia, Wijmenga, Cisca, Trynka, Gosia, McManus, Ross, Reynolds, John V, O’Sullivan, Jacintha, MacMathuna, Padraic, McGarrigle, Sarah A, Kelleher, Dermot, Vermeire, Severine, Cleynen, Isabelle, Bisschops, Raf, Tomlinson, Ian, Jankowski, Janusz

Volltext

Regulation of the Ca2+ Sensitivity of the Nonselective Cation Channel TRPM4 von Nilius, Bernd, Prenen, Jean, Tang, Jisen, Wang, Chunbo, Owsianik, Grzegorz, Janssens, Annelies, Voets, Thomas, Zhu, Michael X.

Volltext

Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic von Bennett, S, Søreide, K, Gholami, S, Pessaux, P, Teh, C, Segelov, E, Kennecke, H, Prenen, H, Myrehaug, S, Callegaro, D, Hallet, J

Volltext

Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy von Smeets, Dominiek, Miller, Ian S., O’Connor, Darran P., Das, Sudipto, Moran, Bruce, Boeckx, Bram, Gaiser, Timo, Betge, Johannes, Barat, Ana, Klinger, Rut, van Grieken, Nicole C. T., Cremolini, Chiara, Prenen, Hans, Mazzone, Massimiliano, Depreeuw, Jeroen, Bacon, Orna, Fender, Bozena, Brady, Joseph, Hennessy, Bryan T., McNamara, Deborah A., Kay, Elaine, Verheul, Henk M., Maarten, Neerincx, Gallagher, William M., Murphy, Verena, Prehn, Jochen H. M., Koopman, Miriam, Punt, Cornelis J. A., Loupakis, Fotios, Ebert, Matthias P. A., Ylstra, Bauke, Lambrechts, Diether, Byrne, Annette T.

Volltext

Activation of TRPV4 Channels (hVRL-2/mTRP12) by Phorbol Derivatives von Watanabe, Hiroyuki, Davis, John B., Smart, Darren, Jerman, Jeff C., Smith, Graham D., Hayes, Phil, Vriens, Joris, Cairns, William, Wissenbach, Ullrich, Prenen, Jean, Flockerzi, Veit, Droogmans, Guy, Benham, Christopher D., Nilius, Bernd

Volltext

1048P Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: Evidence from a Belgian real-world multicenter study von Delombaerde, D.L., Oeste, C.L., Verbiest, A.T.L., Tack, L., Croes, L., Bassez, I., Hens, D.F.E., Franssen, C., Debruyne, P.R., Prenen, H., De Sutter, J., Vulsteke, C.

Volltext

665P First-in-human, phase Ia/b, dose-escalation/expansion study of KRAS G12C inhibitor BI 1823911, as monotherapy and combined with anticancer therapies, in patients (pts) with ad... von Heymach, J., Kotecki, N., Prenen, H., Alonso, G., Lindsay, C.R., Barve, M., Thamer, C., Eigenbrod-Giese, S., Marotti, M.A., Van Lancker, G.

Volltext

2184TiP Extensive cardiovascular characterization and follow-up of patients receiving immune checkpoint inhibitors: A prospective multicenter study von Delombaerde, D.L., De Sutter, J., Croes, L., Vervloet, D., Moerman, V., Van de Veire, N., Willems, A-M., Wouters, K., Peeters, M., Prenen, H., Vulsteke, C.

Volltext

600TiP A randomized blinded phase II study of ompenaclid (RGX-202-01) vs placebo in combination with FOLFIRI plus bevacizumab (BEV) in patients (pts) with previously treated RAS mu... von Elez Fernandez, M.E., Rosello Keranen, S., Paez, D., Jiménez Castro, J., Rivera Herrero, F., Ruiz-Casado, A., Riesco Martinez, M.C., Montagut Viladot, C., Coupez, D., Ducreux, M.P., Loly, C., Martin-Babau, J., Prenen, H., van den Eynde, M., Borg, C., Cuyle, P-J., de Haar-Holleman, A., Raimbourg, J., Bechar, N., Tabernero, J.

Volltext

1621P Efficacy and safety of erdafitinib in adults with pancreatic cancer and prespecified fibroblast growth factor receptor alterations (FGFRalt) in the phase II open-label: Singl... von Pant, S., Arnold, D., Tabernero, J., Loriot, Y., Folprecht, G., Haag, G.M., Palmer, D., Prenen, H., Coward, J., Lugowska, I., Goeminne, J-C., Cervantes, A., Gutierrez, M., Sweiti, H., Hammond, C., Najmi, S., Thomas, S., Triantos, S., Crow, L., Schuler, M.H.H.

Volltext

604O Phase I dose escalation and initial dose expansion results of AMG 193: A MTA-cooperative PRMT5 inhibitor, in patients (pts) with MTAP-deleted solid tumors von Sacher, A.G., Villalona-Calero, M., O’Neil, B.H., Rodon, J., Doi, T., Postel-Vinay, S., Ghiringhelli, F., Yamamoto, N., Wahlroos, S., Villaruz, L., El-Helali, A., Fujiwara, Y., Addeo, A., Lin, C-C., Fontana, E., Chuang, C-H., Liu, C., Eggert, T., Penel, N., Prenen, H.

Volltext

136P Phase I dose escalation study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1 in solid tumors von Prenen, H., Kyi, C., Van Lancker, G., Patel, S.P., Mittag, D., Weaver, A., Bol, K., Stalbovskaya, V., Pulini, J., Zhou, G., Dong, Z., Asatiani, E., Hodi, F.S.

Volltext

The Selectivity Filter of the Cation Channel TRPM4 von Nilius, Bernd, Prenen, Jean, Janssens, Annelies, Owsianik, Grzegorz, Wang, Chunbo, Zhu, Michael X, Voets, Thomas

Volltext